Pluri (PLUR) Interest Coverage Ratio (2022 - 2025)

Pluri (PLUR) reported Interest Coverage Ratio of 28.16 for Q4 2025, down 19.89% year-over-year from 35.16 in Q4 2024, and down 1.57% quarter-over-quarter from 27.73 in Q3 2025.

Pluri (PLUR) Interest Coverage Ratio (2022 - 2025) Analysis & Trends

Pluri (PLUR) has 4 years of Interest Coverage Ratio data on file, last reported at 28.16 in Q4 2025.

  • Interest Coverage Ratio for Q4 2025 came in at 28.16, down 19.89% year-over-year; the trailing twelve-month figure through Dec 2025 was 27.49 (down 9.33% YoY), and the FY2025 annual result was 25.4, up 0.72% from the prior year.
  • Interest Coverage Ratio eased to 28.16 in Q4 2025 per PLUR's latest filing, from 27.73 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 23.49 in Q4 2024 and troughed at 35.69 in Q3 2022.
  • A 4-year average of 27.8 and a median of 27.7 in 2024 frame the typical range for Interest Coverage Ratio.
  • The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio gained 29.59% in 2023, then retreated 19.89% in 2025.
  • A 4-year view of Interest Coverage Ratio shows it stood at 31.5 in 2022, then gained by 23.39% to 24.13 in 2023, then grew by 2.66% to 23.49 in 2024, then dropped by 19.89% to 28.16 in 2025.
  • Business Quant data shows PLUR's Interest Coverage Ratio at 28.16 in Q4 2025, 27.73 in Q3 2025, and 28.42 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -258.33
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 11.50
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 547.67
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - 11.79
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -28.16

Historic Data

Download Data
DateValue
Dec 31, 2025 -28.16
Sep 30, 2025 -27.73
Jun 30, 2025 -28.42
Mar 31, 2025 -25.47
Dec 31, 2024 -23.49
Sep 30, 2024 -23.95
Jun 30, 2024 -27.68
Mar 31, 2024 -25.39
Dec 31, 2023 -24.13
Sep 30, 2023 -25.13
Jun 30, 2023 -29.75
Mar 31, 2023 -32.72
Dec 31, 2022 -31.50
Sep 30, 2022 -35.69